comparemela.com

Latest Breaking News On - Kisseipharmaceutical co ltd - Page 1 : comparemela.com

ObsEva SA: ObsEva Presents Clinical Data on Oral GnRH Antagonist Linzagolix at Multiple Congresses

-Data featured in two oral presentations at the 8th Society of Endometriosis and Uterine Disorders Congress and a poster presentation at the International Society of Gynecological Endocrinology 20th

United statesKarolinska institutetShauna dillonJacques donnezBrandi howardHugh taylorKristina gemzell danielssonYale school of medicineProgram in uterine fibroidsSociety of endometriosisInternational society of gynecological endocrinologyEuropean commissionDrug administrationInternational societySwiss exchangeUterine disorders congress

Investegate |ObsEva SA Announcements | ObsEva SA: ObsEva Presents Clinical Data on Oral GnRH Antagonist Linzagolix at Multiple Congresses

Investegate announcements from ObsEva SA, ObsEva Presents Clinical Data on Oral GnRH Antagonist Linzagolix at Multiple Congresses

United statesKarolinska institutetShauna dillonJacques donnezBrandi howardHugh taylorKristina gemzell danielssonProgram in uterine fibroidsInternational society of gynecological endocrinologyYale school of medicineSociety of endometriosisDrug administrationInternational societyEuropean commissionSwiss exchangeExchange commission

ObsEva Presents Clinical Data on Oral GnRH Antagonist

-Data featured in two oral presentations at the 8th Society of Endometriosis and Uterine Disorders Congress and a poster presentation at the International.

United statesKarolinska institutetJacques donnezBrandi howardHugh taylorKristina gemzell danielssonYale school of medicineProgram in uterine fibroidsSociety of endometriosisInternational society of gynecological endocrinologyInternational societySwiss exchangeUterine disorders congressCatholic university of louvainKisseipharmaceutical co ltdWorld congress

vimarsana © 2020. All Rights Reserved.